Podcast: IBM and Bird & Bird debate data and IP rights

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Podcast: IBM and Bird & Bird debate data and IP rights

Sponsored by

twobirds-400px.jpg
 L to R: Katharine Stephens, Toby Bond, Steve Mortinger

Charlotte Kilpatrick joins Steve Mortinger of IBM and Toby Bond and Katharine Stephens of Bird & Bird to discuss how data rights are reshaping IP

 

 

To listen to the full podcast, which lasts 40 minutes, click the link above.

In this podcast we delve into some of the biggest issues around intellectual property rights and data use. 

As more industries become reliant on data, the questions of who owns it and how it is generated and shared become more relevant.

Panellists from IBM and Bird & Bird share their thoughts on whether new rights to encourage data collection would further entrench monopolies and stifle innovation. 

If new rights are to be created, there are questions over who should create them and whether they would stifle data sharing.

To learn more about how data is reshaping the IP landscape, check out our 40-minute podcast by clicking on the link above. 



more from across site and SHARED ros bottom lb

More from across our site

Matthew Cassie becomes the tenth partner to join the firm’s London outpost, and the second since it opened its new headquarters in May this year
A&O Shearman and Fish & Richardson invested in German talent, meanwhile, major firms have assembled for an on the merits case pitting KeeeX against OpenAI and Adobe
Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
Palińska is the business & IP law lead at CD Projekt Red in Poland
Schwitulla is the head of litigation management at Nokia in Germany
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Almeida is the IP group leader at Bosch in Brazil
Gift this article